1. Janssen had better Darzalex sales than expected in Q1 (15:01)
2. Alnylam is at the new frontier of medicines: "It will have the same impact on the industry as antibodies" (13:46)
3. Janssen receives new approval for Darzalex in Canada (12:14)
4. WS Audiology plans to list subsidiary (11:04)
5. Denmark discusses vaccine swap with other countries (09:46)
6. Sydbank: Expanded ALK approval is good news (19/04)
7. ALK gains important approval on difficult US market (19/04)
8. Roche publishes new sclerosis data to keep Novartis at bay (19/04)
9. Health organizations see danger in Denmark’s decision to stop using Astrazeneca vaccine (19/04)
10. Top news from MedWatch this week (16/04)
11. EU likely to decline new vaccine deals with Astrazeneca and J&J (16/04)
12. Morgan Stanley: 12 new product launches will pave the way for Ambu (16/04)
13. Danish government makes vaccine production a priority in new life science strategy (16/04)
14. WS Audiology is the no. 1 applicant for patents within hearing aid industry (16/04)
15. Gilead scores new FDA approval for drug obtained in billion-dollar purchase (15/04)

• Project Manager, Unilabs
• Senior Laborant with responsibility for operation and task coordination
• eTMF Manager - Genmab
• Mechanical Design Engineer, with solid experience in 3D CAD
• Senior Scientist, Neuroimmunology and Neuroinflammation, In-vivo, Lundbeck
• R&D Process Manager - Genmab
• Statistical Programmer, Specialist - Lundbeck
• Regulatory Affairs Associate - Orifarm
• Pharmacovigilance Director - Zealand Pharma
• System Engineer for novel stem cell devices - Novo Nordisk
• Development Chemist for Drug Product Development - ALK
• Associate Director, GMP QA, Commercial Operations – Y-mAbs Therapeutics
• Business Process Manager - Orifarm
• Pharmacovigilance Auditor - ALK
• Senior Manager, QA GMP - Genmab
• Senior Scientist (Toxicology) / Nonclinical Safety Specialist
• Manager, SOX Compliance - Zealand Pharma
• Sponsor Oversight Lead - Genmab
• Electronics / HW Engineer for the development of medical devices
• Cross Functional CMC/Safety Toxicologist, Ascendis Pharma
• Senior QMS Professional in Project- and Change Management - ALK
• Senior QA Manager, QA Commercial Operations, Ascendis Pharma
• Senior Manager, Regulatory Affairs CMC, New Markets & Life Cycle Management - Y-mAbs Therapeutics
• Director of Global Marketing - Ascelia Pharma
• Regulatory Affairs Specialist - Orifarm

See all jobs